A new medication, Voclosporin, has been approved to treat lupus in the kidneys (lupus nephritis). We want to learn if this new medicine is the same or better at treating lupus outside the kidney (SLE) than the currently available medicine (Mycophenolate Mofetil). This is especially important because lupus symptoms can vary and the medicine that helps each person best can be different. In this study, we want to understand who would benefit most from one medicine, or the other, or maybe even both together.
At each visit you will meet with a member of the study team and fill out questionnaires, get labs done, and have a physical exam. The study also involves ECG measurements and a willingness to take the study medication regularly. You will need to stop all lupus medications for one month before you get study treatment. The study physician will give you steroids to manage your symptoms during this time.
Up to $850, Study medication at no cost
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Rheumatology Outpatient Center
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Saira Sheikh
Thurston Arthritis Research Center
Clinical or Medical
Interventional
Bones, Joints, Muscles
Chronic Conditions
Immune System/Infections
Minority Health
Rare Diseases
Women's Health
22-2908
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
